Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic.

ABSTRACT: Cancer patients, specifically lung cancer patients, show heightened vulnerability to severe COVID-19 outcomes. The immunological and inflammatory pathophysiological similarities between lung cancer and COVID-19-related ARDS might explain the predisposition of cancer patients to severe COVID-19, while multiple risk factors in lung cancer patients have been associated with worse COVID-19 outcomes, including smoking status, older age, etc. Recent cancer treatments have also been urgently evaluated during the pandemic as potential risk factors for severe COVID-19, with conflicting findings regarding systemic chemotherapy and radiation therapy, while other therapies were not associated with altered outcomes. Given this vulnerability of lung cancer patients for severe COVID-19, the delivery of c

SUBMITTER: Bian DJH 

PROVIDER: S-EPMC9367272 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature